Concepedia

Tong Shen

TS

59

Publications

3.4K

Citations

28

H-Index

1987

Active since

Affiliations

University of Colorado Boulder(Current)

The University of Texas MD Anderson Cancer Center

Guangzhou Medical University

St. John's University

Vanderbilt University

Tong Shen is an author at University of Colorado Boulder specializing in medicine, engineering, and pharmacology.

ORCID

Top concepts

Publications per year

1987–2024

59

Publications

59

KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study

Bijal Shah, Armin Ghobadi, Olalekan O. Oluwole et al. · The Lancet · 2021 · 721 citations · Full text

, , +9

Erlotinib (Tarceva, OSI-774) Antagonizes ATP-Binding Cassette Subfamily B Member 1 and ATP-Binding Cassette Subfamily G Member 2–Mediated Drug Resistance

Zhi Shi, Xing-Xiang Peng, In‐Wha Kim et al. · Cancer Research · 2007 · 326 citations

, , +17

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 264 citations

KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results

Bijal Shah, Michael R. Bishop, Olalekan O. Oluwole et al. · Blood · 2021 · 190 citations · Full text

Human Multidrug Resistance Protein 7 ( <i>ABCC10</i> ) Is a Resistance Factor for Nucleoside Analogues and Epothilone B

Elizabeth Hopper-Borge, Xiu Xu, Tong Shen et al. · Cancer Research · 2008 · 152 citations · Full text

Rows per page

1–5 of 59